Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CUE Cue Biopharma > Detailed Quotes

CUE Cue Biopharma

Watchlist
3.350
-0.070-2.05%
Trading Session  02/01 14:39 ET
High
3.530
Open
3.330
Turnover
219.87K
Low
3.300
Pre Close
3.420
Volume
64.63K
Market Cap
144.19M
P/E(TTM)
Loss
52wk High
7.455
Shares
43.04M
P/E(Static)
Loss
52wk Low
2.180
Float Cap
132.17M
Bid/Ask %
50.00%
Historical High
31.690
Shs Float
39.45M
Volume Ratio
1.00
Historical Low
2.180
Dividend TTM
--
Div Yield TTM
--
P/B
2.84
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.16%
Amplitude
6.73%
Avg Price
3.402
Lot Size
1
Float Cap
132.17M
Bid/Ask %
50.00%
Historical High
31.690
Shs Float
39.45M
Volume Ratio
1.00
Historical Low
2.180
Dividend TTM
--
P/B
2.84
Dividend LFY
--
Turnover Ratio
0.16%
Amplitude
6.73%
Avg Price
3.402
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.
CEO: Mr. Daniel R. Passeri
Market: NASDAQ
Listing Date: 01/02/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist